Literature DB >> 3548263

Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.

M Gawel, R Riopelle, I Libman, S Bouchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3548263

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  1 in total

1.  Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.

Authors:  H Przuntek; D Welzel; M Gerlach; E Blümner; W Danielczyk; H J Kaiser; P H Kraus; H Letzel; P Riederer; K Uberla
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.